Miyuki Ozawa

2.0k citations

26 papers · 1.6k indexed · 1 hit paper · h-index 17

Transplantation top 0.2%
- Renal Transplantation Outcomes and Treatments 17
Nephrology top 2%
- Renal Diseases and Glomerulopathies 6
Immunology top 5%
- T-cell and B-cell Immunology 5
Hepatology top 5%
- Liver Disease and Transplantation 3
Surgery top 5%
- Organ Transplantation Techniques and Outcomes 10
- Transplantation: Methods and Outcomes 3
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 4
Hematology
- Blood groups and transfusion 3

Co-authors: Paul I. Terasaki Lorita M. Rebellato Carl E. Haisch Kimberly P. Briley William T. Kendrick Kazuo Mizutani Karen Parker Paul Bolin
Cited by: Transplantation Nephrology Immunology
Partner nations: United States Japan France

In The Last Decade

Miyuki Ozawa

26 papers receiving 1.5k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2013 Incidence and Impact of De Novo Donor-Specific Alloantibody in Primary Renal Allografts

Peers

Countries citing papers authored by Miyuki Ozawa

Since Specialization

Citations

This map shows the geographic impact of Miyuki Ozawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miyuki Ozawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miyuki Ozawa more than expected).

Fields of papers citing papers by Miyuki Ozawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miyuki Ozawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miyuki Ozawa. The network helps show where Miyuki Ozawa may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Miyuki Ozawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Miyuki Ozawa Line = papers co-authored together Miyuki Ozawa links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Incidence and Impact of De Novo Donor-Specific Alloantibody in Primary Renal Allograftsbreakdown → Matthew J. Everly,Lorita M. Rebellato,Carl E. Haisch,Miyuki Ozawa,Karen Parker,Kimberly P. Briley,Paul G. Catrou,Paul Bolin,William T. Kendrick,Scott A. Kendrick,Robert C. Harland,Paul I. Terasaki	2013	292
2	Predicting Operational Tolerance in Pediatric Living-Donor Liver Transplantation by Absence of HLA Antibodies Kayo Waki,Yasuhiko Sugawara,Koichi Mizuta,Michiko Taniguchi,Miyuki Ozawa,Masaru Hirata,Masumi Nozawa,Junichi Kaneko,Koki Takahashi,Takashi Kadowaki,Paul I. Terasaki,Norihiro Kokudo	2012	17
3	Antibodies to HLA-E may account for the non-donor-specific anti-HLA class-Ia antibodies in renal and liver transplant recipients Mepur H. Ravindranath,Tho D. Pham,Miyuki Ozawa,Paul I. Terasaki	2011	19
4	Factors affecting outcomes of liver transplantation: an analysis of OPTN/UNOS database. Hidenori Ohe,Junichi Hoshino,Miyuki Ozawa	2011	6
5	A report of the epidemiology of de novo donor-specific anti-HLA antibodies (DSA) in "low-risk" renal transplant recipients. Lorita M. Rebellato,Mathew J Everly,Carl E. Haisch,Miyuki Ozawa,Kimberly P. Briley,Karen Parker,Paul G. Catrou,Paul Bolin,William T. Kendrick,Scott A. Kendrick,Robert C. Harland	2011	9
6	HLA-E monoclonal antibodies recognize shared peptide sequences on classical HLA class Ia: Relevance to human natural HLA antibodies Mepur H. Ravindranath,Michiko Taniguchi,Chien-wei Chen,Miyuki Ozawa,Hugo Kaneku,Nadim El‐Awar,Junchao Cai,Paul I. Terasaki	2009	35
7	No Occurrence of De Novo HLA Antibodies in Patients With Early Corticosteroid Withdrawal in a 5-year Prospective Randomized Study Julio C. Delgado,Anne Fuller,Miyuki Ozawa,Lonnie Smith,Paul I. Terasaki,Fuad S. Shihab,David D. Eckels	2009	21
8	Human Leukocyte Antigen Class II DQ Alpha and Beta Epitopes Identified From Sera of Kidney Allograft Recipients Chun-Tsan Deng,Nadim El‐Awar,Miyuki Ozawa,Junchao Cai,Nils Lachmann,Paul I. Terasaki	2008	43
9	Parallel Volume Segmentation and Simplification with Adaptive Tetrahedral Grids Miyuki Ozawa,Akinori Kimura,Yoshio Yamaji,Yasufumi Takama,Satoshi Yamaguchi,Hiromi T. Tanaka	2007	2
10	HLA class II DP epitopes. Chun-Tsan Deng,Junchao Cai,Miyuki Ozawa,Nadim El‐Awar	2007	6
11	Frequency of MIC Antibody in Rejected Renal Transplant Patients without HLA Antibody Kazuo Mizutani,Paul I. Terasaki,Remi Shih,Rui Pei,Miyuki Ozawa,Jar-How Lee	2006	58
12	Association of Kidney Transplant Failure and Antibodies Against MICA Kazuo Mizutani,Paul I. Terasaki,J. Bignon,Maryvonne Hourmant,Anne Cesbron‐Gautier,Remi Shih,Rui Pei,Jar-How Lee,Miyuki Ozawa	2006	56
13	Retrospective antibody analysis of thirty patients with kidney graft failure. Tsuneo Kinukawa,Masashi Kato,Paul I. Terasaki,Miyuki Ozawa	2006	14
14	Predictive Value of HLA Antibodies and Serum Creatinine in Chronic Rejection: Results of a 2-year Prospective Trial Paul I. Terasaki,Miyuki Ozawa	2005	124
15	Serial Ten‐Year Follow‐Up of HLA and MICA Antibody Production Prior to Kidney Graft Failure Kazuo Mizutani,Paul I. Terasaki,Anne Rosén,Violet Esquenazi,Joshua Miller,Remi Shih,Rui Pei,Miyuki Ozawa,Jar-How Lee	2005	177
16	Predicting Kidney Graft Failure by HLA Antibodies: a Prospective Trial Paul I. Terasaki,Miyuki Ozawa	2004	355
17	EFFECTS OF CHANGES IN THE CRITERIA FOR NATIONALLY SHARED KIDNEY TRANSPLANTS FOR HLA-MATCHED PATIENTS1 Yoshinobu Hata,J. Michael Cecka,Steven K. Takemoto,Miyuki Ozawa,Yong W. Cho,Paul I. Terasaki	1998	22
18	Binding of IgG to B cell via HLA molecules David Chia,Paul I. Terasaki,Henry Chan,Miyuki Ozawa	1991	6
19	Clinical evaluation of serum neuron-specific enolase level in patients with lung cancer. Yukiko Mori,Hiroaki Hoshi,Seishi Jinnouchi,Kuniko Harada,Kouji Onoe,Shigeki Nagamachi,Miyuki Ozawa,Katsushi Watanabe,Yoshihiro Tawara	1987	1
20	Lysinoalanine Formation in the Processing of Quick-Served Noodle Keiko Abe,Miyuki Ozawa,Seiichi Homma,Masao Futimaki	1981	1

About Miyuki Ozawa

Miyuki Ozawa is a scholar working on Transplantation, Nephrology and Hepatology, having authored 26 papers that have together received 1.6k indexed citations. Recurring topics across this work include Renal Transplantation Outcomes and Treatments (17 papers), Organ Transplantation Techniques and Outcomes (10 papers), Renal Diseases and Glomerulopathies (6 papers), T-cell and B-cell Immunology (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Liver Disease and Transplantation (3 papers), Transplantation: Methods and Outcomes (3 papers) and Blood groups and transfusion (3 papers). The work is most often cited by research in Transplantation (1.3k citations), Nephrology (370 citations) and Immunology (542 citations). Miyuki Ozawa has collaborated with scholars based in United States, Japan and France. Frequent co-authors include Paul I. Terasaki, Lorita M. Rebellato, Carl E. Haisch, Kimberly P. Briley, William T. Kendrick, Kazuo Mizutani, Karen Parker, Paul Bolin, Scott A. Kendrick and Jar-How Lee.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact